Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.865 USD | +3.43% | +1.58% | +69.71% |
07/05 | Transcript : Heron Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
07/05 | Heron Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+69.71% | 417M | |
+23.82% | 44.96B | |
+1.13% | 42.65B | |
+46.11% | 41.85B | |
-4.27% | 29.04B | |
+10.97% | 26.08B | |
-20.70% | 19.03B | |
+5.59% | 12.75B | |
+28.14% | 12.06B | |
-3.93% | 11.75B |
- Stock Market
- Equities
- HRTX Stock
- News Heron Therapeutics, Inc.
- Needham Adjusts Price Target on Heron Therapeutics to $6 From $7, Maintains Buy Rating